47
8
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T7317 |
CU-CPT-9a
|
TLR | Immunology/Inflammation |
CU-CPT-9a 是TLR8特异性拮抗剂,IC50值为 0.5 nM。 | |||
T27076 |
8-Cyclopentyl-1,3-dimethylxanthine
CPT,A1受体拮抗剂,CPT |
Adenosine Receptor | GPCR/G Protein; Neuroscience |
8-Cyclopentyl-1,3-dimethylxanthine (CPT) 是一种选择性的腺苷A1受体拮抗剂,对 A1 受体和 A2 受体的Ki 值分别为 10.9 和 1440 nM。 | |||
T22698 |
TLR3-IN-1
CU CPT 4a |
TLR | Immunology/Inflammation |
TLR3-IN-1 (CU CPT 4a) 是一种选择性的TLR3信号抑制剂,在 RAW 264.7 细胞中 IC50 为 3.44 μM。它可以抑制 TLR3/dsRNA 复合物介导的下游信号通路,并抑制全细胞中 TNF-α 和 IL-1β 的产生。 | |||
T7347 |
CU-CPT-8m
TLR8-specific antagonist |
TLR | Immunology/Inflammation |
CU-CPT-8m (TLR8-specific antagonist) 是TLR8特异性拮抗剂,IC50值为 67 nM。 | |||
T7302 |
CU-CPT9b
CU-CPT-9b,TLR8-specific antagonist 1 |
TLR | Immunology/Inflammation |
CU-CPT9b (TLR8-specific antagonist 1) 是 toll 样受体 8 (TLR8) 的拮抗剂,Kd 为 21 nM。它抑制由 TLR8 激动剂 R-848 在过表达 TLR8 的 HEK-Blue 细胞中诱导的 NF-ĸB 活化,IC50 值为 0.7 nM。 | |||
T24610 |
Pegamotecan
Prothecan,PEG-camptothecin,PEG-beta-CPT |
Topoisomerase | DNA Damage/DNA Repair |
Pegamotecan (PEG-camptothecin)是一种拓扑异构酶I(TOP1)抑制剂,具有抗癌活性,它可用于治疗食管癌、非小细胞肺癌和胰腺癌。 | |||
T41018 |
CPT-157633
|
||
CPT-157633 is a difluoro-phosphonomethyl phenylalanine derivative that acts as a potent inhibitor of the enzyme PTP1B. It effectively prevents the development of glucose intolerance induced by binge drinking. | |||
T38696 | Rp-8-CPT-cAMPS | ||
Rp-8-CPT-cAMPS is a powerful and competitive antagonist of cAMP-induced activation of cAMP-dependent protein kinase (PKA) I and II. Acting as a potent cAMP analog, Rp-8-CPT-cAMPS exhibits a preference for site A of RI over site A of RII. Additionally, it favors site B of RII over site B of RI. This compound effectively inhibits cAMP-dependent PKA activation and demonstrates selectivity in binding to specific sites within the protein kinase. | |||
T10899 |
CU-CPT17e
|
TLR | Immunology/Inflammation |
CU-CPT17e 是多Toll 样受体激动剂,可激活TLR3、TLR8和TLR9。 | |||
T15020 |
CU-CPT22
|
TLR | Immunology/Inflammation |
CU-CPT22 是 toll 样受体 1 和 2 蛋白复合物抑制剂,可阻断 Pam3CSK4诱导的 TLR1/2 激活,IC50值为 0.58 µM。 它与 TLR1/2 结合的合成三酰脂蛋白竞争,Ki 值为 0.41 µM。 | |||
T38694 |
Sp-8-CPT-cAMPS
|
||
Sp-8-CPT-cAMPS is a powerful and specific cAMP analog that activates cAMP-dependent protein kinase A (PKA I and PKA II) selectively and effectively. It exhibits a 153-fold preference for site A of RI over site A of RII, and a 59-fold preference for site B of RII over site B of RI. | |||
T36678 |
Rp-8-CPT-cAMPS sodium
|
||
Rp-8-CPT-cAMP is a structural combination of the lipophilic and non-hydrolyzable cAMP analogs, 8-CPT-cyclic AMP and Rp-cyclic AMPS .[1] It functions as a site-selective inhibitor of protein kinase A (PKA) type I and II, with preference towards site A of type I and site B of type II.2 By occupying cAMP binding sites at the regulatory subunit of PKA, Rp-8-CPT-cAMP prevents the kinase holoenzyme from dissociative activation.[2],[3] | |||
T22014 |
8-CPT-2Me-cAMP, sodium salt
|
||
8-CPT-2Me-cAMP sodium is a sodium salt compound that selectively activates exchange proteins activated by cAMP (Epac). These Epac proteins are cAMP-sensitive guanine nucleotide exchange factors (GEFs) responsible for activating small GTPases Rap1 and Rap2. 8-CPT-2Me-cAMP sodium specifically activates Epac1 with an EC50 value of 2.2 μM, while showing no activation of PKA with an EC50 value greater than 10 μM [1]. Additionally, 8-CPT-2Me-cAMP sodium stimulates the Epac-mediated release of calcium ... | |||
T21705 |
8-CPT-Cyclic AMP (sodium salt)
|
||
8-CPT-Cyclic AMP (8-CPT-cAMP) sodium 是环 AMP 依赖性蛋白激酶的选择性激活剂。 8-CPT-Cyclic AMP sodium 也是有效的环 GMP 特异性磷酸二酯酶(PDE VA)抑制剂,IC50为 0.9 μM。 8-CPT-Cyclic AMP sodium 还抑制 PDE III 和 PDE IV,IC50分别为 24 和 25 μM。8-CPT-Cyclic AMP sodium 对 Epac 具有非常高的亲和力,是一种有效的Epac 活化剂。 | |||
T73421 |
CPT-Se3
|
Topoisomerase | DNA Damage/DNA Repair |
CPT-Se3为含硒的喜树碱前体活性分子,其杀癌和抗肿瘤效力显著。它通过降低GSH/GSSG比率及总硫醇水平,增加Hep G2细胞中ROS含量,触发癌细胞凋亡。CPT-Se3对HeLa、Hep G2、A549及SMMC-7721细胞线具备显着细胞毒性,IC50值介于2.19-4.7 μM。 | |||
T73422 |
CPT-Se4
|
Topoisomerase | DNA Damage/DNA Repair |
CPT-Se4为含硒前体活性分子的喜树碱(CPT)衍生物,对癌细胞具有较高杀伤力和抑制肿瘤生长效果。在降低GSH/GSSG比率和总硫醇的同时,CPT-Se4能够增加Hep G2细胞中的ROS水平,触发癌细胞凋亡。此化合物对HeLa、Hep G2、A549和SMMC-7721细胞系显示出显著的细胞毒性,IC50值范围为2.54-6.4 μM。 | |||
T4535 |
Etomoxir sodium salt
(R)-(+)-乙莫克舍钠盐,(R)-Etomoxir sodium salt,Na salt,Etomoxir |
Apoptosis; Others | Apoptosis; Others |
Etomoxir sodium salt ((R)-Etomoxir sodium salt) 是一种肉碱棕榈酰转移酶 1a (CPT-1a) 抑制剂,可以阻断脂肪酸合成。Etomoxir sodium salt 具有抗肿瘤活性。 | |||
T78569 |
CPT2
Carnitine palmitoyltransferase 2 |
Apoptosis | Apoptosis |
CPT2 (Carnitine palmitoyltransferase 2) 是一种脂肪酸氧化过程中的酶,它在结直肠癌 (CRC) 预后评估中作为生物标志物。CPT2 通过过表达激活p-p53并增加p53蛋白水平,这有助于抑制肿瘤生长和促进细胞的凋亡。CPT2 缺乏是长链脂肪酸氧化障碍相关的常见遗传性疾病,并且CPT2 的表达降低与多种癌症的发展密切相关,因此,在癌症研究领域具有研究价值。 | |||
T8344 |
CPTH2
|
Apoptosis; Histone Acetyltransferase | Apoptosis; Chromatin/Epigenetic |
CPTH2 是一种组蛋白乙酰基转移酶抑制剂。它选择性地抑制Gcn5对组蛋白 H3 的乙酰化,通过抑制乙酰转移酶p300 (KAT3B)诱导凋亡并降低透明细胞肾癌细胞系的侵袭性。 | |||
T64643 | Rh2(S-TCPTAD)4 | ||
Rh2(S-TCPTAD)4 是一种有用的有机化合物,可用于生命科学领域的相关研究,其产品编号为 T64643。 | |||
T77873 |
NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT hydrochloride
|
Topoisomerase | DNA Damage/DNA Repair |
NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT(化合物I)盐酸盐是一种通过偶联抗体实现靶向细胞传递的拓扑异构酶I抑制剂,显示出优良的体内外ADC活性。 | |||
T22549 |
ACPT-I
|
Others | Others |
Agonist for group III mGlu receptors | |||
T39941 |
MP-PEG4-Val-Lys-Gly-7-MAD-MDCPT
MP-PEG4-Val-Lys-Gly-7-MAD-MDCPT |
||
MP-PEG4-Val-Lys-Gly-7-MAD-MDCPT is a Camptothecin-linker. MP-PEG4-Val-Lys-Gly-7-MAD-MDCPT is a drug-linker conjugate for antibody-drug conjugate (ADC). | |||
T22550 |
ACPT-II
|
Others | Others |
metabotropic receptor antagonist | |||
T22536 |
8-pCPT-2-O-Me-cAMP-AM
|
Others | Others |
Epac activator | |||
T74750 |
NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT
|
||
NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT(化合物I)作为一种拓扑异构酶I抑制剂,通过偶联抗体实现对细胞的靶向传递,展现出良好的体内外ADC活性。 | |||
T81752 |
MP-PEG8-Val-Lys-Gly-7-MAD-MDCPT
|
||
MP-PEG8-Val-Lys-Gly-7-MAD-MDCPT为喜树碱-接头化合物,属于抗体偶联活性分子(drug-linker conjugate for ADC)部分。该化合物在癌症及自身免疫性疾病研究中显示出研究潜力。 | |||
T22693 |
CPTH2 (hydrochloride) (357649-93-5 free base)
CPTH2 (hydrochloride) |
Others | Others |
CPTH2 is an inhibitor of the HAT activity of Gcn5. | |||
T72756 |
Gly-7-MAD-MDCPT
|
||
Gly-7-MAD-MDCPT 是一种抗癌剂。Gly-7-MAD-MDCPT 是一种喜树碱 (Camptothecin) 化合物,对多种癌细胞有细胞毒性,IC50为 10-1000 nM。 | |||
T40879 |
7-MAD-MDCPT
|
||
7-MAD-MDCPT, a Camptothecin analog, is a toxin payload in antibody drug conjugates (ADCs). | |||
T74751 | Br-Val-Ala-NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT | ||
Br-Val-Ala-NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT (Formula V),作为抗体偶联药物(ADC)的药物连接体部分,该化合物通过linker与topoisomeraseI抑制剂相连。 | |||
T25409 |
FCPT
|
||
FCPT is an ATP competitive kinesin-5 inhibitor. | |||
T12408 |
Perhexiline maleate
|
Others; Mitochondrial Metabolism | Metabolism; Others |
Perhexiline maleate 是一种口服活性的 CPT1和 CPT2抑制剂,可降低脂肪酸的代谢。Perhexiline maleate 对大鼠心脏和肝脏CPT 1的IC50值分别为77 和 148 μM。 | |||
T4535L |
Etomoxir
(R)-(+)-Etomoxir |
Antioxidant; CPT | Metabolism; oxidation-reduction |
Etomoxir 是肉碱棕榈酰转移酶 1a (CPT-1a) 抑制剂,通过抑制 CPT-1a 来抑制脂肪酸氧化,且抑制人、大鼠和豚鼠中棕榈酸酯的氧化。Etomoxir 对腺嘌呤核苷酸转位酶有抑制作用,可通过破坏CoA稳态来抑制巨噬细胞极化。 | |||
T11978 |
McN3716
NSC359682,Methyl palmoxirate |
Mitochondrial Metabolism; CPT | Metabolism |
McN3716 是一种肉碱棕榈酰转移酶 I (CPT-1) 抑制剂,可用于研究代谢疾病。 | |||
T9088 |
Topovale
ARC111,ARC 111,ARC-111,Topoval |
Topoisomerase | DNA Damage/DNA Repair |
Topovale (ARC111) 是一种有效的拓扑异构酶 I 抑制剂。Topovale 抑制缺氧介导的缺氧诱导因子 1alpha 的积累。 Topovale 对一组癌细胞表现出低 nM 细胞毒性。与 P388 细胞相比,在 CPT 抗性拓扑异构酶 I (TOP1) 缺陷的 P388/CPT45 细胞中,Topovale 细胞毒性和 Topovale 诱导的细胞凋亡减少了 > 100 倍。 | |||
T27831 |
Lifibrate
|
||
Lifibrate is an inhibitor of cholinephosphotransferase (CPT), phosphatidyl-N,N-dimethylethanolamine N-methyltransferase (PDE-NMT), and phosphatidyl-N-methylethanolamine N-methyltransferase (PME-NMT). | |||
T78069 |
RPR132595A hydrochloride
NPC hydrochloride |
Drug Metabolite | Metabolism |
RPR132595A (NPC) hydrochloride,CPT-11的活性代谢产物,由细胞色素P-450 3A4 (CYP3A4) 催化产生,经尿液排出体外。 | |||
T38474 |
CL2-MMT-SN38
CL2-MMT-SN38 |
||
CL2-MMT-SN38 is a derivative of SN-38, which is a potent anticancer agent and the active metabolite of Irinotecan (CPT-11), a Topoisomerase I inhibitor. | |||
T14454 |
Azido-PEG5-acid
|
Others | Others |
Azido-PEG5-acid is a non-cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs), such as the conjugate CPT-APO (CPT: Camptothecin. | |||
T19553 |
RPR132595A
NPC |
Others | Others |
RPR132595A is an active CPT-11 metabolite, it is generated by cytochrome P-450 3A4 (CYP3A4). | |||
T70380 |
ZBH-1205
|
||
ZBH-1205 is a novel camptothecin derivative, revealing potent antitumor activities mainly through cell apoptosis pathway, being more effective than cpt-11 and sn38 at inhibiting topoismerase-1 | |||
T74494 |
Antitumor agent-63
|
||
Antitumor agent-63(Compound 40),一种20 (S)-O-linked camptothecin (CPT) 糖复合物,作为抗肿瘤剂,对正常细胞展现出无毒性。该化合物表现出高稳定性和低topoisomeraseI (Topo I)直接抑制活性。 | |||
T68196 |
Aminocarnitine
|
||
Aminocarnitine is an inhibitor of fatty acid oxidation that acts as a hypoglycemic and antiketogenic compound. It alters lipidic metabolism by inhibiting carnitine acetyltransferase (CAT) and carnitine palmitoyltransferase (CPT). | |||
T73829 | Malonyl CoA | ||
Malonyl CoA是脂肪酸生物合成的重要底物,同时也担任脂肪酸氧化过程中的抑制剂角色。此外,Malonyl CoA亦作为线粒体肉碱棕榈酰转移酶1(CPT1)的可逆性抑制剂。 | |||
T78711 |
A011
|
ATM/ATR | DNA Damage/DNA Repair; PI3K/Akt/mTOR signaling |
A011,作为一种选择性的ataxia-telangiectasia mutated (ATM)抑制剂,其IC50为1.0 nM,能够在与CPT-11联合应用时,诱导Apoptosis及G2/M期细胞周期阻滞,显示出显著的抗肿瘤活性。 | |||
T77816 |
Deruxtecan analog 2
|
||
Deruxtecananalog 2(示例9 P3)是一种含活性分子-linker的Deruxtecan类似物,由Camptothecin(一种对多种癌症如结直肠癌、乳腺癌、肺癌和卵巢癌具有抗肿瘤活性的Topo I抑制剂)和linker组成,主要用于开发针对EGFR2的抗体药物偶联物(ADC)活性分子。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3S1957 |
9-amino-CPT
9-氨基喜树碱,Aminocamptothecin,9-amino-2(S)-camptothecin,9-Aminocamptothecin |
Topoisomerase | DNA Damage/DNA Repair |
9-amino-CPT (Aminocamptothecin) 是一种拓扑异构酶I 的抑制剂,具有抗肿瘤活性。 | |||
T6228 |
Irinotecan
CPT-11,Topotecin,伊立替康,(+)-Irinotecan |
Topoisomerase; Autophagy | Autophagy; DNA Damage/DNA Repair |
Irinotecan (CPT-11) 是喜树碱的衍生物,是一种 DNA 拓扑异构酶 I (Topo I) 的抑制剂。Irinotecan 通过与 Topo I 复合物结合来阻止 DNA 链的重新连接,并导致双链 DNA 断裂和细胞死亡,具有抗肿瘤活性。 | |||
T1123 |
Camptothecin
NSC-100880,Campathecin,喜树碱,(S)-(+)-Camptothecin,CPT |
Apoptosis; Influenza Virus; Topoisomerase; Antibiotic; Antifungal | Apoptosis; DNA Damage/DNA Repair; Microbiology/Virology |
Camptothecin (CPT) 属于生物碱类天然产物,是一种 DNA 拓扑异构酶 I (Topo I) 的抑制剂 (IC50=679 nM),具有特异性。Camptothecin 具有抗肿瘤活性,可以诱导细胞凋亡。 | |||
T0486L |
Irinotecan Hydrochloride
盐酸伊立替康,伊立替康盐酸盐,Camptothecin 11 hydrochloride,CPT-11 hydrochloride |
Topoisomerase; Autophagy | Autophagy; DNA Damage/DNA Repair |
Irinotecan Hydrochloride (CPT-11 hydrochloride) 是喜树碱半合成衍生物的盐酸盐,是一种拓扑异构酶 I 抑制剂,可研究结肠癌和直肠癌。 | |||
T0486 |
Irinotecan hydrochloride trihydrate
Irinotecan HCl Trihydrate,CPT-11 HCl Trihydrate,盐酸伊立替康三水合物 |
Topoisomerase; Autophagy | Autophagy; DNA Damage/DNA Repair |
Irinotecan hydrochloride trihydrate (CPT-11 HCl Trihydrate) 通过抑制拓扑异构酶 1 来防止 DNA 展开,可研究结肠癌和直肠癌。 | |||
T4S1951 |
10-Methoxycamptothecin
|
Others | Others |
10-Methoxycamptothecin 是分离自喜树的喜树碱衍生物,具有高抗癌特性。通过对 2774 细胞系的抗肿瘤活性测定,发现它比 10-羟基喜树碱的细胞毒性更高。 | |||
T3S1955 |
7-Ethylcamptothecin
|
Others | Others |
7-Ethylcamptothecin 是一种喜树碱类似物。其中喜树碱是一种细胞毒性生物碱,从喜树中分离出得到,对 L1210 白血病和 Walker 256 癌肉瘤模型具有很强的抗肿瘤活性。 | |||
TN2460 |
12-Ethyl-9-hydroxycamptothecin
7-乙基-10-羟基喜树碱,7-Ethyl-10-Hydroxy-Camptothecin |
Others | Others |
12-Ethyl-9-hydroxycamptothecin 是一种 Camptothecin 的衍生物。其中Camptothecin (CPT) 是一种生物碱,也是 DNA 拓扑异构酶I 抑制剂(IC50:679 nM)。 |